Plain-English translation of NCT07889388 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing the RIGHTEST iFree 2, a small sensor you wear on your arm that continuously measures your blood sugar levels throughout the day. Researchers want to make sure this device works accurately and safely for pregnant women with diabetes, and that it helps them manage their blood sugar during pregnancy.
Pregnant women with diabetes need to monitor their blood sugar very carefully to stay healthy and protect their baby. This trial exists to make sure the RIGHTEST iFree 2 is reliable and safe to use during pregnancy, so women have a trustworthy tool for managing their diabetes.
You likely qualify if…
You likely don't qualify if…
You will wear two RIGHTEST iFree 2 sensors on your upper arms simultaneously for up to 15 days. You'll also come in for one visit lasting up to 6 hours where medical staff will take several blood samples to compare with your sensor readings and check how accurately the device is measuring your blood sugar. The sensors stay on your skin and give you continuous readings throughout each day.
AI-generated summary from trial data · Nov 15, 2026 · Not medical advice
Germany